Public Employees Retirement System of Ohio Increases Stock Holdings in Sotera Health (NASDAQ:SHC)

Public Employees Retirement System of Ohio grew its holdings in shares of Sotera Health (NASDAQ:SHC) by 14.3% during the third quarter, Holdings Channel reports. The firm owned 54,706 shares of the company’s stock after purchasing an additional 6,826 shares during the quarter. Public Employees Retirement System of Ohio’s holdings in Sotera Health were worth $914,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in the business. Wedmont Private Capital boosted its holdings in Sotera Health by 6.5% in the third quarter. Wedmont Private Capital now owns 10,915 shares of the company’s stock valued at $169,000 after purchasing an additional 664 shares during the period. First Citizens Bank & Trust Co. boosted its stake in shares of Sotera Health by 5.0% in the 3rd quarter. First Citizens Bank & Trust Co. now owns 14,287 shares of the company’s stock valued at $239,000 after buying an additional 677 shares during the period. CWM LLC grew its position in shares of Sotera Health by 86.1% during the second quarter. CWM LLC now owns 2,146 shares of the company’s stock worth $25,000 after buying an additional 993 shares in the last quarter. GAMMA Investing LLC grew its position in shares of Sotera Health by 125.0% during the third quarter. GAMMA Investing LLC now owns 2,988 shares of the company’s stock worth $50,000 after buying an additional 1,660 shares in the last quarter. Finally, TD Asset Management Inc increased its stake in shares of Sotera Health by 1.5% during the second quarter. TD Asset Management Inc now owns 123,454 shares of the company’s stock worth $1,465,000 after buying an additional 1,800 shares during the period. Institutional investors and hedge funds own 91.03% of the company’s stock.

Analyst Ratings Changes

SHC has been the subject of a number of recent research reports. The Goldman Sachs Group began coverage on shares of Sotera Health in a research note on Friday, December 6th. They issued a “neutral” rating and a $14.00 price target for the company. Royal Bank of Canada reaffirmed an “outperform” rating and set a $17.00 price objective on shares of Sotera Health in a research report on Thursday, November 21st. Finally, Citigroup increased their target price on Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a report on Wednesday, November 6th. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat, Sotera Health has a consensus rating of “Moderate Buy” and an average price target of $16.08.

Sotera Health Stock Up 0.5 %

Shares of NASDAQ:SHC opened at $13.27 on Friday. The firm has a 50 day simple moving average of $14.43 and a 200-day simple moving average of $14.20. Sotera Health has a twelve month low of $10.71 and a twelve month high of $17.44. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. The company has a market capitalization of $3.76 billion, a PE ratio of 53.08 and a beta of 1.96.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.01). The company had revenue of $285.47 million during the quarter, compared to analysts’ expectations of $278.64 million. Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. Sotera Health’s revenue was up 8.5% on a year-over-year basis. During the same period last year, the firm earned $0.18 earnings per share. On average, equities analysts predict that Sotera Health will post 0.61 EPS for the current fiscal year.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.